Letter From The Editor

Another reason to monitor glucose: Better restaurant service Over the past few weeks I have started increasing my race walking mileage to prepare for a half marathon in November. Although I don’t have diabetes this increase in physical activities seems to run my glucose low in the morning. While driving …

Humulin U-500 insulin once again is on my agenda, as I had three calls from hospital pharmacists and educators asking for a method to convert and write orders for patients on pumps and for sliding scale use. Many of our syringe or pen patients are injecting 60 or more units …

There seems to be a lot going on in the glucose testing world this week in response to the FDA announcing potential problems with strips that use glucose dehydrogenase pyrroloquinoline quinone (GDH-PQQ) to evaluate levels of glucose in the blood. (See this week’s Item #3.)  Multiple companies are sending out …

Steve and I spent a busy 4 days at the AADE, learning the value of education and tighter glucose control for the patients. We would like to thank the nearly 1000 AADE members that stopped by our booth and tried the slow carb muffins. While I was touring the exhibit hall …

This is an exciting week for many of our readers. As you receive this newsletter over 3,000 of the most recognized experts in Diabetes Care, CDE’s, will be gathering in Atlanta for the American Association of Diabetes Educator’s 36th Annual Meeting. This year there is a lot to talk about. …

Over the past couple of years there have been studies released and commentaries written about the detrimental effects of tight glycemic control. The studies seem to say tight control is not good, yet the practitioners say it is. Now, in the July 27, 2009, issue of the Archives of Internal …

It seems like every pump patient I’ve ever worked with in the last ten years was calling me this past week about the recent recall of Medtronic’s Quick Set Devices with lot numbers beginning with #8. Many of them had heard outrageous stories about the recall. With this in mind …

The controversy about Lantus and cancer continues to heat up. Leading experts are coming forward to share their opinions on the meta-analysis. It is too bad that the lay press will never get these expert opinions to our patients. Last week Diabetes Technology & Therapeutics published an outstanding editorial by three …

The American Society of Metabolic and Bariatric Surgery met last week and released new information — be sure to check out this week’s Items 12 through 15. You have seen the backlash from the recent studies on Lantus and Cancer and already other insulin manufacturers are touting their products for …

EXTRA – SPECIAL JULY 6th EDITION:  Top Clinicians Share Lantus Guidance  Click here for the inside stories…   Lantus Cancer Concern Inconclusive Details of a new study, “Lantus insulin: a possible link with cancer which requires further investigation,”to be published in the Journal of the EASD, “Diabetologia,” have been leaked. This …